• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about gene therapy

    Recent news which mentions gene therapy

    < Previous 1 2 3 Next >
    Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
    Tickers AGTC
    Tags Briefs Benzinga Biotech
    From Benzinga
    Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
    Tickers ADVM
    Tags News Briefs Penny Stocks
    From Benzinga
    FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
    Tickers PFE
    Tags Market News General FDA
    From Benzinga
    Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
    Tickers OCGN
    Tags OCGN Market News News
    From Benzinga
    Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
    Tags Biotechnology antibody cell therapy
    From PRUnderground
    Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
    Tickers FOLD
    Tags Benzinga Biotech Movers
    From Benzinga
    FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
    Tickers BLUE NTLA
    Tags Market News BLUE News
    From Benzinga
    Why Bluebird Bio Shares Are Tumbling Today
    Tickers BLUE
    Tags Movers Biotech Benzinga
    From Benzinga
    Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
    Tickers ARYD FOLD
    Tags Benzinga Biotech Movers
    From Benzinga
    Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
    Tickers TAK TKPHF
    Tags TAK gene therapy Health Care
    From Benzinga
    FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
    Tickers BMRN
    Tags Biotech Health Care Benzinga
    From Benzinga
    RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
    Tickers RGNX
    Tags Small Cap General Phase 2 Trial
    From Benzinga
    After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
    Tickers AVRO
    Tags News Phase 1 Trial Health Care
    From Benzinga
    Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
    Tickers SGMO
    Tags General Small Cap Fabry disease
    From Benzinga
    Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
    Tickers SIOX
    Tags Management General Benzinga
    From Benzinga
    Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
    Tickers TSHA
    Tags News TSHA Briefs
    From Benzinga
    Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
    Tickers TSHA
    Tags Biotech Movers Benzinga
    From Benzinga
    FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
    Tickers FBIO MBIO
    Tags FDA General Phase 2 Trial
    From Benzinga
    FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
    Tickers BLUE
    Tags Briefs Biotech Benzinga
    From Benzinga
    Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
    Tickers SRPT
    Tags Biotech Health Care gene therapy
    From Benzinga
    Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
    Tickers BLUE
    Tags Benzinga Movers Biotech
    From Benzinga
    BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
    Tickers BMRN
    Tags Health Care gene therapy Benzinga
    From Benzinga
    Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
    Tickers PFE
    Tags News Health Care Trading Ideas
    From Benzinga
    Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
    Tickers ADVM
    Tags Briefs Biotech Benzinga
    From Benzinga
    Why Are Bluebird Bio Shares Trading Lower Today?
    Tickers BLUE
    Tags FDA General Small Cap
    From Benzinga
    Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
    Tickers BLUE
    Tags FDA General Small Cap
    From Benzinga
    UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
    Tickers QURE
    Tags Small Cap Huntington's Disease General
    From Benzinga
    New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
    Tickers BLUE
    Tags ASH21 BLUE Market News
    From Benzinga
    Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
    Tickers BLUE
    Tags BLUE Market News ASH21
    From Benzinga
    Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
    Tickers SELB
    Tags SELB Trading Ideas gene therapy
    From Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.